Regen-008S1
The purpose of this study is to evaluate the long-term safety of up to two gelatin-hydrogel formulation REACT injections given 3 to 6 months apart and delivered percutaneously into same kidney on renal function in participants with chronic kidney…
- Investigator
- Mark S Segal
- Status
- Accepting Candidates
- Ages
- 30 Years - 80 Years
- Sexes
- All
REGEN-006
The purpose of this study is to assess the safety and efficacy (including durability) of up to 2 REACT injections given 3 months (+30 days) apart and delivered percutaneously into biopsied and non-biopsied contralateral kidneys in participants with…
- Investigator
- Mark S Segal
- Status
- Accepting Candidates
- Ages
- 30 Years - 80 Years
- Sexes
- All
aHUS REGISTRY
- Investigator
- Mark S Segal
- Status
- Accepting Candidates